Menu
Back to Journals » Drug Design, Development and Therapy » Volume 16
Original Research
Risk Factors for Hepatic Encephalopathy in Hepatocellular Carcinoma After Sorafenib or Lenvatinib Treatment: A Real-World Study
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 3,959 | Dovepress* | 3,445+ | 108 | 3,553 | |
| PubMed Central* | 514 | 108 | 622 | ||
| Totals | 3,959 | 216 | 4,175 | ||
| *Since 28 December 2022 | |||||
View citations on PubMed Central and Google Scholar